{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260805758066/en/Summit-Therapeutics-Further-Expands-Ivonescimab-Global-Development-Program-with-Phase-IIIII-HARMONi-GU1-Study-in-1L-Bladder-Cancer", "message": "News view counter 866691 successfully enlarged"}